Abstract:Obesity-induced adipose inflammation has been demonstrated to be a key cause of insulin resistance. Peptides derived from bovine alpha-lactalbumin have been shown to inhibit the activities of dipeptidyl peptidase IV (DPP-IV) and angiotensin converting enzyme (ACE), scavenge 2,2'-azinobis [3-ethylbenzothiazoline-6-sulfonate] (ABTS+) radical and stimulate glucagon-like peptide-2 secretion. In the present study, the effects of bovine alpha-lactalbumin hydrolysates (alpha-LAH) on adipose insulin resistance and inflammation induced by high-fat diet (HFD) were investigated. The insulin resistance model was established by feeding C57BL/6J mice with HFD (60% kcal from fat) for eight weeks. Then, the mice were fed with HFD and bovine alpha-LAH of different doses (100 mg/kg b.w., 200 mg/kg b.w. and 400 mg/kg b.w.) for another 12 weeks to evaluate its protective effects against HFD-induced insulin resistance. The oral glucose tolerance test (OGTT) and intraperitoneal insulin tolerance test (ipITT) were conducted after intervention with alpha-LAH for 10 weeks and 11 weeks, respectively. Results showed that bovine alpha-LAH significantly reduced body weight, blood glucose, serum insulin, and HOMA-IR (homeostatic model assessment of insulin resistance) levels, lowered the area-under-the-curve (AUC) during OGTT and ipITT, and downregulated inflammation-related gene [tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, monocyte chemoattractant protein (MCP)-1] expression in adipose tissues of HFD-fed C57BL/6J mice. Furthermore, bovine alpha-LAH also suppressed insulin receptor substrate 1 (IRS-1) serine phosphorylation (Ser307, Ser612), enhanced protein kinase B (known as Akt) phosphorylation, and inhibited the activation of inhibitor of kappaB kinase (IKK) and mitogen activated protein kinase (MAPK) signaling pathways in adipose tissues of HFD-fed C57BL/6J mice. These results suggested that bovine alpha-LAH could ameliorate adipose insulin resistance and inflammation through IKK and MAPK signaling pathways in HFD-fed C57BL/6J mice.

Α-Lactalbumin Ameliorates Hepatic Lipid Metabolism in High-Fat-diet Induced Obese C57BL/6J Mice

Peptides Released from Bovine Α-Lactalbumin by Simulated Digestion Alleviated Free Fatty Acids-Induced Lipid Accumulation in HepG2 Cells

Bovine α-Lactalbumin Hydrolysates (α-LAH) Ameliorate Adipose Insulin Resistance and Inflammation in High-Fat Diet-Fed C57BL/6J Mice

Bovine α-Lactalbumin Hydrolysates (α-LAH) Ameliorate Adipose Insulin Resistance and Inflammation in High-Fat Diet-Fed C57BL/6J Mice.

Bovine α-lactalbumin hydrolysates ameliorate obesity-associated endotoxemia and inflammation in high-fat diet-fed mice through modulation of gut microbiota.

Bovine Α-Lactalbumin Hydrolysates (Α-Lah) Attenuate High-Fat Diet Induced Nonalcoholic Fatty Liver Disease by Modulating Hepatic Lipid Metabolism in C57BL/6J Mice

Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway

Lactoferrin attenuates high-fat diet-induced hepatic steatosis and lipid metabolic dysfunctions by suppressing hepatic lipogenesis and down-regulating inflammation in C57BL/6J mice

A-Lactalbumin Peptide Asp-Gln-Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids-Treated HepG2 Cells and High-Fat Diet-Induced NAFLD Mice by Activating the PPARa Pathway

Pea Albumin Extracted from Pea (Pisum sativum L.) Seeds Ameliorates High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease by Regulating Lipogenesis and Lipolysis Pathways

Lactobacillus acidophilus JYLA-126 Ameliorates Obesity-Associated Metabolic Disorders by Positively Regulating the AMPK Signaling Pathway Through the Gut-Liver Axis

Albumin Deficiency Reduces Hepatic Steatosis and Improves Glucose Metabolism in a Mouse Model of Diet-Induced Obesity

Lactobacillus Alleviated Obesity Induced by High-Fat Diet in Mice.

Modulation of the Microbiome-Fat-Liver Axis by Lactic Acid Bacteria: A Potential Alleviated Role in High-Fat-Diet-Induced Obese Mice.

Lactobacillus Plantarum HF02 Alleviates Lipid Accumulation and Intestinal Microbiota Dysbiosis in High-Fat Diet-Induced Obese Mice.

Α-Lipoic Acid Attenuates Obesity-Associated Hippocampal Neuroinflammation and Increases the Levels of Brain-Derived Neurotrophic Factor in Ovariectomized Rats Fed a High-Fat Diet.

Α-Lactalbumin Peptide Asp-Gln-Trp Alleviates Hepatic Insulin Resistance and Modulates Gut Microbiota Dysbiosis in High-Fat Diet-Induced NAFLD Mice.

Pea Albumin Extracted from Pea (pisum Sativum L.) Seed Protects Mice from High Fat Diet-Induced Obesity by Modulating Lipid Metabolism and Gut Microbiota

Extract of Acalypha australis L. inhibits lipid accumulation and ameliorates HFD-induced obesity in mice through regulating adipose differentiation by decreasing PPARγ and CEBP/α expression

Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction-associated steatotic liver disease and intestinal barrier integrity in obesity-induced mice

Bifidobacterium Animalis Subsp. Lactis A12 Prevents Obesity- Associated Dyslipidemia by Modulating Gut Microbiota-Derived Short-Chain Fatty Acid Production and Energy Metabolism in High-Fat Diet-Fed Mice